Abstract:-Transgenic mouse models have been developed to manipulate beta-adrenergic receptor (betaAR) signal transduction. Although several of these models have altered betaAR subtypes, the specific functional sequelae of betaAR stimulation in murine heart, particularly those of beta2-adrenergic receptor (beta2AR) stimulation, have not been characterized. In the present study, we investigated effects of beta2AR stimulation on contraction, [Ca2+]i transient, and L-type Ca2+ currents (ICa) in single ventricular myocytes isolated from transgenic mice overexpressing human beta2AR (TG4 mice) and wild-type (WT) littermates. Baseline contractility of TG4 heart cells was increased by 3-fold relative to WT controls as a result of the presence of spontaneous beta2AR activation. In contrast, beta2AR stimulation by zinterol or isoproterenol plus a selective beta1-adrenergic receptor (beta1AR) antagonist CGP 20712A failed to enhance the contractility in TG4 myocytes, and more surprisingly, beta2AR stimulation was also ineffective in increasing contractility in WT myocytes. Pertussis toxin (PTX) treatment fully rescued the ICa, [Ca2+]i, and contractile responses to beta2AR agonists in both WT and TG4 cells. The PTX-rescued murine cardiac beta2AR response is mediated by cAMP-dependent mechanisms, because it was totally blocked by the inhibitory cAMP analog Rp-cAMPS. These results suggest that PTX-sensitive G proteins are responsible for the unresponsiveness of mouse heart to agonist-induced beta2AR stimulation. This was further corroborated by an increased incorporation of the photoreactive GTP analog [gamma-32P]GTP azidoanilide into alpha subunits of Gi2 and Gi3 after beta2AR stimulation by zinterol or isoproterenol plus the beta1AR blocker CGP 20712A. This effect to activate Gi proteins was abolished by a selective beta2AR blocker ICI 118,551 or by PTX treatment. Thus, we conclude that (1) beta2ARs in murine cardiac myocytes couple to concurrent Gs and Gi signaling, resulting in null inotropic response, unless the Gi signaling is inhibited; (2) as a special case, the lack of cardiac contractile response to beta2AR agonists in TG4 mice is not due to a saturation of cell contractility or of the cAMP signaling cascade but rather to an activation of beta2AR-coupled Gi proteins; and (3) spontaneous beta2AR activation may differ from agonist-stimulated beta2AR signaling.

Tyrosine 308 is Necessary for Ligand-directed Gs Protein-biased Signaling of Β2-Adrenoceptor

Two naturally occurring mutations of human GPR103 define distinct G protein selection bias

Distinct Conformations of GPCR–β-arrestin Complexes Mediate Desensitization, Signaling, and Endocytosis

Stereochemistry Of An Agonist Determines Coupling Preference Of Beta(2)-Adrenoceptor To Different G Proteins In Cardiomyocytes

The beta 2 adrenergic receptor cross-linked interactome identifies 14-3-3 proteins as regulating the availability of signaling-competent receptors

Different conformational responses of the <sub>2</sub>-adrenergic receptor-Gs complex upon binding of the partial agonist salbutamol or the full agonist isoprenaline

Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor

Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias

Cell Logic For Dual Coupling Of A Single Class Of Receptors To G(S) And G(I) Proteins

Structure and dynamics determine G protein coupling specificity at a class A GPCR

Β 2 -Adrenergic Stimulation Compartmentalizes Β 1 Signaling into Nanoscale Local Domains by Targeting the C-Terminus of Β 1 -Adrenoceptors

Coupling of Beta(2)-Adrenoceptor to G(I) Proteins and Its Physiological Relevance in Murine Cardiac Myocytes

Multiple Ligand-Specific Conformations of the Β2-Adrenergic Receptor

Angiotensin II cyclic analogs as tools to investigate AT1R biased signaling mechanisms

Analysis of <sub>2</sub>AR-G<sub>s</sub> and <sub>2</sub>AR-G<sub>i</sub> complex formation by NMR spectroscopy

Control of conformational equilibria in the human B2 bradykinin receptor. Modeling of nonpeptidic ligand action and comparison to the rhodopsin structure

Genetic Evidence That Β-Arrestins Are Dispensable for the Initiation of Β2-Adrenergic Receptor Signaling to ERK

Gα i is required for carvedilol-induced β 1 adrenergic receptor β-arrestin biased signaling

Different conformational responses of the β2-adrenergic receptor-Gs complex upon binding of the partial agonist salbutamol or the full agonist isoprenaline

Advances in Receptor Conformation Research: the Quest for Functionally Selective Conformations Focusing on the Β2-Adrenoceptor.

G Alpha(I) Is Required For Carvedilol-Induced Beta(1) Adrenergic Receptor Beta-Arrestin Biased Signaling